He is the executive Secretary of the Chilean HIV Guidelines panel and of the panel for Latin American Standards for HIV Diagnosis, Care and Treatment in collaboration with API and PAHO.

We evaluated safety, efficacy, and emergent resistance in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV-1 with at least two-class drug resistance.

Dec 15, 2024 · Fue un éxito el VII IMPROVING STANDARDS IN HIV CARE que, en su séptima versión nos cautivará con las más recientes evidencias científicas que han estado en la contingencia de los últimos...

Jul 20, 2019 · Purpose: One year away from 90-90-90 WHO goals, a final 52% of viral suppression among people living with HIV (PLWH) in Latin America (LA) was reported by UNAIDS in 2017, based upon estimations...

Diagnosis of HIV Infection Using Mass Community Rapid Testing in Santiago, Chile

Sep 14, 2017 · "This is an epidemic spread that is out of control," says Dr. Carlos Beltrán, an infectious diseases specialist and the head of Sida Chile, a non-governmental organization of physicians...

Progress of the dual elimination of mother to child transmission of HIV and congenital syphilis in Latin America and the Caribbean Mónica Alonso González, Washington DC, USA Treatment as prevention: can antiretrovirals control the epidemic? Guidelines: Regional differences/changes Carlos Beltran, Santiago, Chile

Sin Tacos Ni Corbata conversó con el infectólogo y presidente de la corporación Sida Chile, Carlos Beltrán, sobre cómo el VIH está siendo abordado en medio de la pandemia por Covid-19 donde en Chile, durante los últimos cinco años, ha habido un aumento del 46% de las personas que portan este virus de transmisión sexual.

Health & HIV. HIV Lead CNWL. National Speciality Advisor for HIV Honorary Associate Professor Institute of Global Health, University College London 18:20-19:10 hrs “Estado de la Epidemia del VIH en las Américas, ¿qué debemos de hacer para mejorar?” Dr. Carlos Beltrán Presidente VILA Asociación Panamericana de Infectología

Oct 28, 2013 · Coreceptor antagonists are a family of antiretroviral drugs that are used with the prior knowledge of patients HIV-1 tropism. Viral RNA-based tropism detection requires a plasma viral load ≥1000 copies/mL, while proviral DNA-based detection can be performed regardless of plasma viral load.